Mckesson Medical-Surgical Inc. Corporate Office: Drug Recall
Recall #D-0400-2025 · 04/25/2025
Class II: Risk
Recall Details
- Recall Number
- D-0400-2025
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Mckesson Medical-Surgical Inc. Corporate Office
- Status
- Ongoing
- Date Initiated
- 04/25/2025
- Location
- Richmond, VA, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3
Reason for Recall
Severe thunderstorms caused transit delays of certain cold chain products that were shipped on 02-Apr-2025 and delivered after the 48-hours specified delivery time, on 07-Apr-2025 and 08-Apr-2025. The affected products may not have been stored at the recommended labeled storage conditions which may have impacted the safety, quality, identity, potency and purity of the product.
Product Description
Medroxyprogesterone Acetate Injectable Suspension, USP, 150 mg / mL, 1 mL Single-Dose Vial, Rx only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, NDC 55150-0330-01
Distribution Pattern
Distributed to Medical Facilities in MS and FL.
Other Recalls by Mckesson Medical-Surgical Inc. Corporate Office
- Class II: Risk 07/30/2025
- Class II: Risk 04/25/2025
- Class II: Risk 04/24/2025
- Class II: Risk 04/24/2025
- Class II: Risk 04/24/2025
View all recalls by Mckesson Medical-Surgical Inc. Corporate Office →
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.